Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
Ann Vasc Surg. 2024 Nov;108:317-324. doi: 10.1016/j.avsg.2024.05.013. Epub 2024 Jul 11.
Primary hyperhidrosis is a condition caused by an excessive stimulation of sweat glands, leading to a decline in both quality of life and social wellbeing. Thoracic sympathectomy surgery provides a relief of the initial symptoms but poses a risk for developing compensatory hyperhidrosis (CH) in various degrees.
The aim of this study was to assess the occurrence and characteristics of CH post-thoracic sympathectomy.
A retrospective cohort study of patients who underwent video-assisted thoracic sympathectomy surgery at level T2-T3 between 2016 and 2022 was conducted. Patients' data were retrieved from medical records and through a telephone interview.
A total of 50 patients (32 males and 18 females) were operated on with a mean ± standard deviation (SD) age of 25.9 ± 7.4 years at the time of surgery for palmoplantar hyperhidrosis. Initial symptoms started in childhood at a mean ± SD age of 11.4 ± 3.3 years. Postoperatively, 39 patients (78%) developed CH, more prevalent in males (64.1%) compared to females (35.8%). This CH mainly affected the back and abdomen (100%), followed by the groin and thighs (28.2%), and, to a lesser extent, the craniofacial area (15.3%). Onset of symptoms occurred within 1 week after surgery in 71.7% of cases, with 71.7% reporting mild to moderate symptoms. CH was significantly associated with higher age at the time of surgery, smoking status, and a longer time lapse in the surgery operation (P value < 0.05).
Thoracic sympathectomy is an effective procedure with a high success rate. Despite a relatively higher occurrence of CH, most patients experience milder symptoms and express satisfaction, noting that their expectations were met following the surgery.
原发性多汗症是一种由于汗腺过度刺激引起的疾病，导致生活质量和社交幸福感下降。胸交感神经切除术可以缓解初期症状，但存在不同程度发展为代偿性多汗症（CH）的风险。
本研究旨在评估胸交感神经切除术后 CH 的发生和特征。
对 2016 年至 2022 年间在 T2-T3 水平接受电视辅助胸腔镜交感神经切除术的患者进行回顾性队列研究。从病历和电话访谈中检索患者数据。
共有 50 例患者（32 名男性和 18 名女性）接受了手掌多汗症的手术治疗，平均年龄为 25.9±7.4 岁。初期症状于平均年龄为 11.4±3.3 岁的儿童期开始。术后 39 例（78%）患者出现 CH，男性（64.1%）比女性（35.8%）更为常见。这种 CH 主要影响背部和腹部（100%），其次是腹股沟和大腿（28.2%），程度较轻的是头面部（15.3%）。71.7%的患者在术后 1 周内出现症状，71.7%的患者报告症状为轻度至中度。CH 与手术时年龄较大、吸烟状况以及手术时间延长显著相关（P 值<0.05）。
胸交感神经切除术是一种有效且成功率高的手术。尽管 CH 的发生率相对较高，但大多数患者出现的症状较轻，并且对手术结果表示满意，认为达到了他们的期望。
